| GA20340-5mg |
|
727727-66-4 |
(Val²)-Amyloid β-Protein (1-6)
|
0 |
C35H51N11O11 |
|
|
|
| GA20339-1mg |
|
— |
(Val²)-Amyloid β-Protein (1-42)
|
0 |
C205H315N55O60S |
|
|
|
| GA20339-005mg |
|
— |
(Val²)-Amyloid β-Protein (1-42)
|
0 |
C205H315N55O60S |
|
|
|
| GA20338-5mg |
|
— |
(Val¹²⁵⁹)-Laminin α-4 Chain (1259-1266) (human)
|
0 |
— |
|
|
|
| GA20338-1mg |
|
— |
(Val¹²⁵⁹)-Laminin α-4 Chain (1259-1266) (human)
|
0 |
— |
|
|
|
| GA20337-25mg |
|
55614-10-3 |
|
0 |
C63H98N18O14S |
|
|
|
| GA20337-5mg |
|
55614-10-3 |
|
0 |
C63H98N18O14S |
|
|
|
| GA20336-25mg |
|
145702-79-0 |
(Tyr⁶⁹,Ala⁷¹·⁷²,Lys⁷⁴)-C3a (69-77)
|
0 |
C45H77N13O11 |
|
|
|
| GA20336-5mg |
|
145702-79-0 |
(Tyr⁶⁹,Ala⁷¹·⁷²,Lys⁷⁴)-C3a (69-77)
|
0 |
C45H77N13O11 |
|
|
|
| GA20335-5mg |
|
157952-15-3 |
(Tyr⁶⁵,Phe⁶⁷)-C5a (65-74) (human)
|
0 |
C55H85N15O16S |
|
|
|
| GA20335-1mg |
|
157952-15-3 |
(Tyr⁶⁵,Phe⁶⁷)-C5a (65-74) (human)
|
0 |
C55H85N15O16S |
|
|
|
| GA20334-1mg |
|
147658-54-6 |
(Tyr⁵·¹²,Lys⁷)-Polyphemusin II
|
0 |
C109H164N38O22S4 |
|
|
|
| GA20334-005mg |
|
147658-54-6 |
(Tyr⁵·¹²,Lys⁷)-Polyphemusin II
|
0 |
C109H164N38O22S4 |
|
|
|
| GA20333-25mg |
|
108437-89-4 |
|
0 |
C77H110N22O19S |
|
|
|
| GA20333-5mg |
|
108437-89-4 |
|
0 |
C77H110N22O19S |
|
|
|
| GA20332-25mg |
|
67338-70-9 |
|
0 |
C74H108N24O19S |
|
|
|
| GA20332-5mg |
|
67338-70-9 |
|
0 |
C74H108N24O19S |
|
|
|
| GA20331-1mg |
|
213779-11-4 |
(Tyr³⁶)-pTH-Related Protein (1-36) (human, mouse, rat)
|
0 |
C194H303N59O53 |
|
|
|
| GA20331-005mg |
|
213779-11-4 |
(Tyr³⁶)-pTH-Related Protein (1-36) (human, mouse, rat)
|
0 |
C194H303N59O53 |
|
|
|
| GA20330-1mg |
|
86292-93-5 |
(Tyr³⁴)-pTH (7-34) amide (bovine)
|
0 |
C156H244N48O40S2 |
|
|
|
